526
Views
7
CrossRef citations to date
0
Altmetric
Respiratory Medicine: Original Article

Long-term safety and efficacy of ambrisentan in Japanese adults with pulmonary arterial hypertension

, , , , &
Pages 1069-1076 | Accepted 13 Apr 2012, Published online: 15 May 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Qin-Hua Zhao, Fu-Hua Peng, Zai-Xin Yu, Gang-Cheng Zhang, Qiu-Shang Ji, Yong Wang, Jin-Ming Liu, Yong Huo, Xiao-Feng Zeng, Jian-Hui Li, Lu Zi & Zhi-Cheng Jing. (2020) Effect of ambrisentan on echocardiographic and Doppler measures from patients in China with pulmonary arterial hypertension. Expert Review of Cardiovascular Therapy 18:9, pages 643-649.
Read now
Andrew J. Peacock, William Zamboni & Carmine Dario Vizza. (2015) Ambrisentan for the treatment of adults with pulmonary arterial hypertension: a review. Current Medical Research and Opinion 31:9, pages 1793-1807.
Read now

Articles from other publishers (5)

Qinhua Zhao, Na Guo, Jun Chen, Daniel Parks & Zhuang Tian. (2021) Comparative assessment of efficacy and safety of ambrisentan and bosentan in patients with pulmonary arterial hypertension: A meta‐analysis. Journal of Clinical Pharmacy and Therapeutics 47:2, pages 146-156.
Crossref
Xinmei Li & Te Li. (2020) Combined Methods (Formal Adjusted Indirect Comparison, Meta-Analysis and Principal Component Analysis) Comparisons of the Safety and Efficacy of Ambrisentan, Bosentan, and Sildenafil in the Patients With Pulmonary Arterial Hypertension. Frontiers in Pharmacology 11.
Crossref
Tomohiko Takahashi, Satoru Hayata, Akihiro Kobayashi, Yuna Onaka, Takeshi Ebihara & Terufumi Hara. (2017) Surveillance on The Safety and Efficacy of Ambrisentan (Volibris Tablet 2.5 mg) in Patients with Pulmonary Arterial Hypertension in Real Clinical Practice: Post-marketing Surveillance (Interim Analysis Report). Clinical Drug Investigation 38:3, pages 219-229.
Crossref
Y. Huo, Z. C. Jing, X. F. Zeng, J. M. Liu, Z. X. Yu, G. C. Zhang, Y. Li, Y. Wang, Q. S. Ji, P. Zhu, B. X. Wu, Y. Zheng, P. P. Wang & J. Li. (2016) Evaluation of efficacy, safety and tolerability of Ambrisentan in Chinese adults with pulmonary arterial hypertension: a prospective open label cohort study. BMC Cardiovascular Disorders 16:1.
Crossref
Xue-Qin Li, Yun-Jing Li & Yong Wang. (2015) Ambrisentan May Improve Exercise Tolerance and Cardiac Function in Patients With Pulmonary Hypertension. Clinical Therapeutics 37:6, pages 1270-1279.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.